Navigation Links
U.S. Turns Spotlight on Medicine's Most Puzzling Cases

Undiagnosed Diseases Program seeks to advance knowledge of mysterious conditions

MONDAY, May 19 (HealthDay News) -- A new research program designed to help patients with mysterious health conditions that can't be diagnosed was announced Monday by the U.S. National Institutes of Health.

The Undiagnosed Diseases Program will study the most puzzling medical cases referred to the NIH Clinical Center by doctors across the United States. The goals are to improve disease management for individual patients and to advance general medical knowledge of these conditions.

The program will utilize existing facilities and staff at the NIH Clinical Center, the National Human Genome Research Institute, and the NIH Office of Rare Diseases.

"A small number of patients suffer from symptoms that do not correspond to known conditions, making their care and treatment extraordinarily difficult. However, the history of biomedical research has taught us that careful study of baffling cases can provide new insights into the mechanisms of disease -- both rare and common," NIH Director Dr. Elias A. Zerhouni said in a prepared statement.

Each patient enrolled in the program will be evaluated by more than 25 senior attending physicians at the NIH Clinical Center, the nation's clinical research hospital. The physicians' specialties include endocrinology, immunology, oncology, dermatology, dentistry, cardiology and genetics.

"We have developed a stringent referral process to ensure this program deals with those cases that have truly confounded medical experts. We will be very selective when it comes to patient eligibility. Our focus is strictly on conditions that have not been diagnosed," said program director Dr. William A. Gahl, who is clinical director at the National Human Genome Research Institute.

To be considered for the program, patients must be referred by a physician and provide all medical records and diagnostic tests requested by the NIH. The estimated 100 patients a year who meet the program's criteria will undergo additional evaluation (which may take up to a week) at the NIH Clinical Center.

In organizing the program, the NIH has contacted patient advocacy groups that provide information and support for people struggling with mysterious conditions.

"We hope to build upon our strong working relationships with many patient advocacy groups. These organizations provide a crucial link in our nation's efforts to improve health through biomedical research," Stephen Groft, director of the NIH Office of Rare Diseases, said in a prepared statement.

"We hope that this new partnership of NIH researchers, advocacy groups and patients will give hope for many Americans who now face troubling medical symptoms with no clear diagnosis," Groft said.

More information

Here's where you can find the Undiagnosed Diseases Program.

-- Robert Preidt

SOURCE: U.S. National Institutes of Health, news release, May 19, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
2. Health and Pension Benefits Provider Turns to Xiotechs TimeScale Replication Services to Protect Critical Data
3. New Jersey Entrepreneur Turns a Page for Four National Charities
4. Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates
5. Worlds Miracle Baby Turns One
6. BET Networks Award-Winning Rap-It-Up HIV/AIDS Campaign Returns to New York City for The Youth Empowerment Tour on November 13-16
7. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
8. Fitness Sensation Susan Powter Returns to Her Legions of Fans and Followers with Focus on Whole Body Wellness Program
9. Brain Turns to Positive Thoughts When Faced With Death
10. Speaking of Womens Health Community Event Returns to All Wal-Mart Supercenters Nationwide January 12th
11. San Francisco City Hall Turns Pink, Draws Attention to Disparities in Breast Cancer Screening, Treatment
Post Your Comments:
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... On November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction ... , “We wake up every day excited to rebuild lives and it’s an honor ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/26/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact ... and reliability. , The new Q-Suite 6 platform is based on the latest Java ... into a specific piece of software for many key components of the suite. Much ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
Breaking Medicine Technology: